Croatian Croatian
en Englishaf Afrikaanssq Albanianar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbg Bulgarianca Catalanzh-CN Chinese (Simplified)zh-TW Chinese (Traditional)hr Croatiancs Czechda Danishnl Dutchet Estoniantl Filipinofi Finnishfr Frenchgl Galicianka Georgiande Germanel Greekht Haitian Creoleiw Hebrewhi Hindihu Hungarianis Icelandicid Indonesianga Irishit Italianja Japaneseko Koreanlv Latvianlt Lithuanianmk Macedonianms Malaymt Malteseno Norwegianfa Persianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsw Swahilisv Swedishth Thaitr Turkishuk Ukrainianur Urduvi Vietnamesecy Welshyi Yiddish

Najnovije vijesti

Genetska terapija AMT-060 za hemofiliju B sprječava krvarenja do 5 godina, probne emisije u tijeku

Genetska terapija AMT-060 za hemofiliju B sprječava krvarenja do 5 godina, probne emisije u tijeku

Vijesti o hemofiliji danas

Povratak na vrh
Slika

Please enable the javascript to submit this form

O nama

Podržano obrazovnim grantovima Bayer -a, BioMarina, Freeline Therapeutics Limited, Pfizer Inc., Shire, Spark Therapeutics i uniQure, Inc.

Osnovni SSL